MedTrace Logo

Feasibility of a Cognitive Intervention for Youth Post Concussion

NCT03195738 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-06-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility and effects of a cognitive intervention for youth following concussion

Conditions

  • Mild Traumatic Brain Injury
  • Concussion, Mild

Interventions

OTHER

Cognitive Orientation to Occupational Performance (CO-OP)

In the CO-OP intervention participants are first assisted to identify 3-5 occupation based goals which then become the focus of the intervention sessions. Over the course of the 10 intervention sessions, participants are guided to learn and practice problem solving using a metacognitive strategy, "Goal-Plan-Do-Check" applied to their self-identified goals. Study therapists use 'guided discovery' an iterative technique to facilitate problem solving by the participant to develop plans to work toward their goals and to evaluate their progress. Intervention takes place in the location that is most meaningful for the participant's selected goal (e.g. home, school, playground etc.). Participants are provided with a work book to track progress.

Sponsors & Collaborators

  • Ontario Society of Occupational Therapists

    collaborator UNKNOWN

  • Holland Bloorview Kids Rehabilitation Hospital

    lead OTHER

Principal Investigators

  • Anne W Hunt, PhD · Bloorview Research Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-25
Primary Completion
2016-03-30
Completion
2016-07-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195738 on ClinicalTrials.gov